 |
|
Short-term Efficacy and Safety of Ranibizumab for Neovascular Age-related Macular Degeneration in the Real World: A Post-marketing Surveillance Study
Se Joon Woo, Ga Eun Cho, Joon Hee Cho
Korean J Ophthalmol. 2019;33(2):150-166. Published online 2019 Apr 8 DOI: https://doi.org/10.3341/kjo.2018.0081
|
|
Citations to this article as recorded by
 Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study
Asim K. Ghosh, Usha S. Nikumbh, Chaitanya K. Shukla, Rohit S. Laul, Abhishek Dixit, Santosh K. Mahapatra, Sameera Nayak, Urmil M. Shah, Sandeep Parwal, Narendran Venkatapathy, Natasha Radhakrishnan, Anup Kelgaonkar, Sandeep Saxena, Divyansh Mishra, Vivek
Ophthalmology and Therapy.2024;[Epub] CrossRef Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis® (Ranibizumab) Biosimilar
Eunji Kim, Jihyeon Han, Yunjung Chae, Hyerim Park, Saerom Kim, Seokkyun Kim, Jungmin Lee, Beom Chan Kim
Ophthalmology and Therapy.2022; 11(2): 639. CrossRef A real-world study assessing the impact of retinal fluid on visual acuity outcomes in patients with neovascular age-related macular degeneration in Korea
Jae Hui Kim, Min Sagong, Se Joon Woo, Yu Cheol Kim, Heeyoon Cho, Young Hoon Lee, Iksoo Byon, Young Joon Jo, Hee Seung Chin, Youkyung Lee, Jae Eun Chae, Se Woong Kang
Scientific Reports.2022;[Epub] CrossRef Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
Shashikant Sharma, Vishali Gupta, Aniruddha Maiti, Sribhargava Natesh, Sandeep Saxena, Vivek Dave, Vimal Parmar, Raju Sampangi, Hemanth Murthy, Sandhya Dharwadkar, Naresh Kumar Yadav, Shrinivas Joshi, Rahul Mayor, Dhanashree Ratra, Soumyava Basu, Neha Goe
International Journal of Retina and Vitreous.2021;[Epub] CrossRef Eyes that Do Not Meet the Eligibility Criteria of Clinical Trials on Age-Related Macular Degeneration: Proportion of the Real-World Patient Population and Reasons for Exclusion
Jae Hui Kim, Jong Woo Kim, Chul Gu Kim, Carlo Cagini
Journal of Ophthalmology.2021; 2021: 1. CrossRef Real-World Effectiveness, Treatment Pattern, and Safety of Ranibizumab in Korean Patients with Neovascular Age-Related Macular Degeneration: Subgroup Analyses from the LUMINOUS Study
Min Sagong, Se Joon Woo, Youkyung Lee
Clinical Ophthalmology.2021; Volume 15: 1995. CrossRef Efficacy of anti-vascular endothelial growth factor agents for treating neovascular age-related macular degeneration in vitrectomized eyes
Yongseok Mun, Kyu Hyung Park, Sang Jun Park, Se Joon Woo, Manuel Alberto de Almeida e Sousa Falcão
PLOS ONE.2021; 16(6): e0252006. CrossRef
|